Article Details

Apexigen Announces Presentation of Phase 2 Clinical Data on CD40 Antibody, Sotigalimab ...

Retrieved on: 2021-05-19 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

Apexigen Announces Presentation of Phase 2 Clinical Data on CD40 Antibody, Sotigalimab .... View article details on hiswai:

Excerpt

... Immunotherapy's Phase 2 clinical trial evaluating sotigalimab, Apexigen's monoclonal antibody targeting CD40, in combination therapy for patients ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up